Investor Relations

Contact

Contact-image
Address:
OxySure Therapeutics, Inc. (Ticker: OXYS)

10880 John W. Elliott Road, Suite 600
Frisco, TX 75033 USA
Tel: (+1) 208-361-6624
Fax: (+1) 972-294-6501
Website : www.oxysure.com
Email: investors@oxysure.com

FDA approval number: K052396
FDA Establishment Registration number: 3004167951
FDA Owner/Operator number: 10023108
Texas Department of Health Authorization Number: 823744
General Services Administration (GSA) Contract number: V797P4153B
Common Stock CUSIP number: 69208T 101

Contact Form

Send an email. All fields with an * are required.

Other information

Other information:

 

 

Investor Relations

 OxySure Therapeutics, Inc. (Ticker: OXYS)

 10880 John W. Elliott Road, Suite 600

 Frisco, TX 75033 USA

Tel: 972-294-6461

Fax: 972-294-6501

 Website : www.oxysure.com

 Email: investors@oxysure.com

 

Other Company Information

 FDA approval number: K052396

 FDA Establishment Registration number: 3004167951

 FDA Owner/Operator number: 10023108

 Texas Department of Health Authorization Number: 823744

General Services Administration (GSA) Contract number: V797P4153B

 Common Stock CUSIP number: 69208T 101